23 related articles for article (PubMed ID: 26178805)
1. Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model.
Mineharu Y; Muhammad AK; Yagiz K; Candolfi M; Kroeger KM; Xiong W; Puntel M; Liu C; Levy E; Lugo C; Kocharian A; Allison JP; Curran MA; Lowenstein PR; Castro MG
Neurotherapeutics; 2012 Oct; 9(4):827-43. PubMed ID: 22996231
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma Biology, Genetics and Possible Therapies.
Castresana JS; Meléndez B
Cells; 2023 Aug; 12(16):. PubMed ID: 37626873
[TBL] [Abstract][Full Text] [Related]
3. Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations.
Ul Ain Q; Lee JH; Woo YS; Kim YH
Arch Pharm Res; 2016 Sep; 39(9):1266-74. PubMed ID: 27381220
[TBL] [Abstract][Full Text] [Related]
4. In vivo gene delivery mediated by non-viral vectors for cancer therapy.
Mohammadinejad R; Dehshahri A; Sagar Madamsetty V; Zahmatkeshan M; Tavakol S; Makvandi P; Khorsandi D; Pardakhty A; Ashrafizadeh M; Ghasemipour Afshar E; Zarrabi A
J Control Release; 2020 Sep; 325():249-275. PubMed ID: 32634464
[TBL] [Abstract][Full Text] [Related]
5. Development of bioactive materials for glioblastoma therapy.
Yang J; Li Y; Zhang T; Zhang X
Bioact Mater; 2016 Sep; 1(1):29-38. PubMed ID: 29744393
[TBL] [Abstract][Full Text] [Related]
6. Viral vector: potential therapeutic for glioblastoma multiforme.
Manikandan C; Kaushik A; Sen D
Cancer Gene Ther; 2020 May; 27(5):270-279. PubMed ID: 31316136
[TBL] [Abstract][Full Text] [Related]
7. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
8. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
Oh B; Han J; Choi E; Tan X; Lee M
J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor.
Gwak SJ; Che L; Yun Y; Lee M; Ha Y
Yonsei Med J; 2020 Dec; 61(12):1042-1049. PubMed ID: 33251778
[TBL] [Abstract][Full Text] [Related]
10. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
Choi M; Oh J; Rhim T; Lee M
Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
[TBL] [Abstract][Full Text] [Related]
11. Suicide gene therapy using reducible poly (oligo-D-arginine) for the treatment of spinal cord tumors.
Won YW; Kim KM; An SS; Lee M; Ha Y; Kim YH
Biomaterials; 2011 Dec; 32(36):9766-75. PubMed ID: 21924768
[TBL] [Abstract][Full Text] [Related]
12. Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model.
Kim HA; Lee HL; Choi E; Kim YH; Lee M
J Pharm Sci; 2015 Nov; 104(11):3743-3751. PubMed ID: 26178805
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.
Shir A; Levitzki A
Cell Mol Neurobiol; 2001 Dec; 21(6):645-56. PubMed ID: 12043839
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
